Recent evidence shows that amniotic fluid (AF) contains multiple cell types derived from the developing fetus, and may represent a novel source of stem cells for cell therapy. In this study, we examined the paracrine factors released by human amniotic fluid–derived mesenchymal stem cells (AF-MSCs) and their ability to accelerate the wound-healing process by stimulating proliferation and migration of dermal fibroblasts. AF-MSCs expressed the typical MSC marker proteins CD13, CD29, and CD44 and differentiated into adipocytes, osteoblasts, and chondrocytes when exposed to the appropriate differentiation media. In addition, AF-MSC-conditioned media (AF-MSC-CM) significantly enhanced proliferation of dermal fibroblasts. Antibody-based protein array and enzyme-linked immunosorbent assay (ELISA) indicated that AF-MSC-CM contains various cytokines and chemokines that are known to be important in normal wound healing, including IL-8, IL-6, TGF-β, TNFRI, VEGF, and EGF. Application of AF-MSC-CM significantly enhanced wound healing by dermal fibroblasts via the TGF-β/SMAD2 pathway. Levels of p-SMAD2 were increased by AF-MSC-CM, and both the increase in p-SMAD2 and migration of dermal fibroblasts were blocked by inhibiting the TGF-β/SMAD2 pathway. Moreover, in a mouse excisional wound model, AF-MSC-CM accelerated wound healing. These data provide the first evidence of the potential for AF-MSC-CM in the treatment of skin wounds.
PrusaAR, MartonE, RosnerM, BernaschekG, HengstschlagerM. 2003. Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?Hum Reprod, 18:1489–1493.
3.
TsaiMS, LeeJL, ChangYJ, HwangSM. 2004. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod, 19:1450–1456.
4.
De CoppiP, BartschGJr., SiddiquiMM, XuT, SantosCC, PerinL, MostoslavskyG, SerreAC, SnyderEY, YooJJ, FurthME, SokerS, AtalaA. 2007. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol, 25:100–106.
5.
In't AnkerPS, ScherjonSA, Kleijburg-van der KeurC, NoortWA, ClaasFH, WillemzeR, FibbeWE, KanhaiHH. 2003. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood, 102:1548–1549.
6.
LiY, ChenJ, ChenXG, WangL, GautamSC, XuYX, KatakowskiM, ZhangLJ, LuM, JanakiramanN, ChoppM. 2002. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology, 59:514–523.
TogelF, HuZ, WeissK, IsaacJ, LangeC, WestenfelderC. 2005. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol, 289:F31–F42.
9.
KinnairdT, StabileE, BurnettMS, LeeCW, BarrS, FuchsS, EpsteinSE. 2004. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res, 94:678–685.
10.
NagayaN, KangawaK, ItohT, IwaseT, MurakamiS, MiyaharaY, FujiiT, UematsuM, OhgushiH, YamagishiM, TokudomeT, MoriH, MiyatakeK, KitamuraS. 2005. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation, 112:1128–1135.
11.
NagayaN, FujiiT, IwaseT, OhgushiH, ItohT, UematsuM, YamagishiM, MoriH, KangawaK, KitamuraS. 2004. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol, 287:H2670–H2676.
12.
LiuCH, HwangSM. 2005. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine, 32:270–279.
van PollD, ParekkadanB, ChoCH, BerthiaumeF, NahmiasY, TillesAW, YarmushML. 2008. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology, 47:1634–1643.
15.
NakanishiC, YamagishiM, YamaharaK, HaginoI, MoriH, SawaY, YagiharaT, KitamuraS, NagayaN. 2008. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun, 374:11–16.
16.
LiH, FuX, OuyangY, CaiC, WangJ, SunT. 2006. Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages. Cell Tissue Res, 326:725–736.
17.
DiegelmannRF, EvansMC. 2004. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci, 9:283–289.
18.
Braiman-WiksmanL, SolomonikI, SpiraR, TennenbaumT. 2007. Novel insights into wound healing sequence of events. Toxicol Pathol, 35:767–779.
19.
RichardsonM. 2004. Acute wounds: an overview of the physiological healing process. Nurs Times, 100:50–53.
20.
BlakytnyR, JudeEB, Martin GibsonJ, BoultonAJ, FergusonMW. 2000. Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol, 190:589–594.
21.
CarringtonLM, BoultonM. 2005. Hepatocyte growth factor and keratinocyte growth factor regulation of epithelial and stromal corneal wound healing. J Cataract Refract Surg, 31:412–423.
22.
EnochS, GreyJE, HardingKG. 2006. ABC of wound healing. Non-surgical and drug treatments. BMJ, 332:900–903.
23.
RioMD, LarcherF, MeanaA, SegoviaJ, AlvarezA, JorcanoJ. 1999. Nonviral transfer of genes to pig primary keratinocytes. Induction of angiogenesis by composite grafts of modified keratinocytes overexpressing VEGF driven by a keratin promoter. Gene Ther, 6:1734–1741.
24.
WernerS, GroseR. 2003. Regulation of wound healing by growth factors and cytokines. Physiol Rev, 83:835–870.
25.
YooSJ, YoonBS, KimJM, SongJM, RohS, YouS, YoonHS. 2005. Efficient culture system for human embryonic stem cells using autologous human embryonic stem cell-derived feeder cells. Exp Mol Med, 37:399–407.
KernS, EichlerH, StoeveJ, KluterH, BiebackK. 2006. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24:1294–1301.
28.
BattulaVL, BareissPM, TremlS, ConradS, AlbertI, HojakS, AbeleH, ScheweB, JustL, SkutellaT, BuhringHJ. 2007. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation, 75:279–291.
29.
YouS, HeoM, MoonJH, KimSC, KwakS, YoonDH, JinD, HongKC, FosterDN, ChoiYJ, KimH. 2004. Establishment of life-span extended bovine fibroblast cells carrying the characterization of primary cells. Mol Cells, 18:261–268.
30.
ShihNR, JoOD, YanagawaN. 2002. Effects of PHEX antisense in human osteoblast cells. J Am Soc Nephrol, 13:394–399.
31.
YoonBS, YooSJ, LeeJE, YouS, LeeHT, YoonHS. 2006. Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-aza-cytidine treatment. Differentiation, 74:149–159.
32.
KhoY, KimS, YoonBS, MoonJH, KimB, KwakS, WooJ, OhS, HongK, KimH, YouS, ChoiY. 2008. Induction of serum amyloid A genes is associated with growth and apoptosis of HC11 mammary epithelial cells. Biosci Biotechnol Biochem, 72:70–81.
33.
MillerGE, ChenE. 2006. Life stress and diminished expression of genes encoding glucocorticoid receptor and beta2-adrenergic receptor in children with asthma. Proc Natl Acad Sci USA, 103:5496–5501.
34.
ParkG, YoonBS, MoonJH, KimB, JunEK, OhS, KimH, SongHJ, NohJY, OhC, YouS. 2008. Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway. J Invest Dermatol, 128:2429–2441.
35.
FurstossO, DoreyK, SimonV, BarilaD, Superti-FurgaG, RocheS. 2002. c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis. EMBO J, 21:514–524.
36.
Mairet-CoelloG, TuryA, DiCicco-BloomE. 2009. Insulin-like growth factor-1 promotes G(1)/S cell cycle progression through bidirectional regulation of cyclins and cyclin-dependent kinase inhibitors via the phosphatidylinositol 3-kinase/Akt pathway in developing rat cerebral cortex. J Neurosci, 29:775–788.
37.
NeuhoffS, MoersJ, RieksM, GrunwaldT, JensenA, DermietzelR, MeierC. 2007. Proliferation, differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro. Exp Hematol, 35:1119–1131.
GalianoRD, MichaelsJ, DobryanskyM, LevineJP, GurtnerGC. 2004. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen, 12:485–492.
40.
ChenL, TredgetEE, WuPY, WuY. 2008. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE, 3:e1886.
41.
NewmanPJ. 1997. The biology of PECAM-1. J Clin Invest, 99:3–8.
42.
HandgretingerR, GordonPR, LeimigT, ChenX, BuhringHJ, NiethammerD, KuciS. 2003. Biology and plasticity of CD133+ hematopoietic stem cells. Ann N Y Acad Sci, 996:141–151.
TakaiK, HaraJ, MatsumotoK, HosoiG, OsugiY, TawaA, OkadaS, NakamuraT. 1997. Hepatocyte growth factor is constitutively produced by human bone marrow stromal cells and indirectly promotes hematopoiesis. Blood, 89:1560–1565.
45.
LabouyrieE, DubusP, GroppiA, MahonFX, FerrerJ, ParrensM, ReiffersJ, de MascarelA, MerlioJP. 1999. Expression of neurotrophins and their receptors in human bone marrow. Am J Pathol, 154:405–415.
46.
ReMC, MonariP, GibelliniD, CiancianainiP, Dall'AglioPP, VignoliM, FurliniG, RamazzottiE, BertazzoniU, CasoliC. 2000. Human T cell leukemia virus type II increases telomerase activity in uninfected CD34+ hematopoietic progenitor cells. J Hematother Stem Cell Res, 9:481–487.
47.
BarrientosS, StojadinovicO, GolinkoMS, BremH, Tomic-CanicM. 2008. Growth factors and cytokines in wound healing. Wound Repair Regen, 16:585–601.
48.
KimWS, ParkBS, SungJH, YangJM, ParkSB, KwakSJ, ParkJS. 2007. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci, 48:15–24.
49.
AgrenMS, WerthenM. 2007. The extracellular matrix in wound healing: a closer look at therapeutics for chronic wounds. Int J Low Extrem Wounds, 6:82–97.
DaCosta ByfieldS, MajorC, LapingNJ, RobertsAB. 2004. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol, 65:744–752.
ZhaoY, WangH, MazzoneT. 2006. Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Exp Cell Res, 312:2454–2464.
54.
FauzaD. 2004. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol, 18:877–891.
55.
PrusaAR, HengstschlagerM. 2002. Amniotic fluid cells and human stem cell research: a new connection. Med Sci Monit, 8:RA253–RA257.
56.
ColterDC, SekiyaI, ProckopDJ. 2001. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA, 98:7841–7845.
YoungHE, SteeleTA, BrayRA, HudsonJ, FloydJA, HawkinsK, ThomasK, AustinT, wardsC, CuzzourtJ, DuenzlM, LucasPA, BlackACJr.2001. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec, 264:51–62.
59.
WuY, ChenL, ScottPG, TredgetEE. 2007. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells, 25:2648–2659.
60.
HorwitzEM, ProckopDJ, FitzpatrickLA, KooWW, GordonPL, NeelM, SussmanM, OrchardP, MarxJC, PyeritzRE, BrennerMK. 1999. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med, 5:309–313.
61.
OrlicD, KajsturaJ, ChimentiS, LimanaF, JakoniukI, QuainiF, Nadal-GinardB, BodineDM, LeriA, AnversaP. 2001. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA, 98:10344–10349.
62.
FinnertyCC, HerndonDN, PrzkoraR, PereiraCT, OliveiraHM, QueirozDM, RochaAM, JeschkeMG. 2006. Cytokine expression profile over time in severely burned pediatric patients. Shock, 26:13–19.
63.
BrauchleM, AngermeyerK, HubnerG, WernerS. 1994. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene, 9:3199–3204.
64.
MatsushimaK, OppenheimJJ. 1989. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine, 1:2–13.
65.
FeugateJE, LiQ, WongL, Martins-GreenM. 2002. The cxc chemokine cCAF stimulates differentiation of fibroblasts into myofibroblasts and accelerates wound closure. J Cell Biol, 156:161–172.
66.
KaneCJ, HebdaPA, MansbridgeJN, HanawaltPC. 1991. Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing. J Cell Physiol, 148:157–173.
67.
RiedelK, RiedelF, GoesslerUR, GermannG, SauerbierM. 2007. Tgf-beta antisense therapy increases angiogenic potential in human keratinocytes in vitro. Arch Med Res, 38:45–51.
68.
MeckmongkolTT, HarmonR, McKeown-LongoP, Van De WaterL. 2007. The fibronectin synergy site modulates TGF-beta-dependent fibroblast contraction. Biochem Biophys Res Commun, 360:709–714.
69.
HosokawaR, UrataMM, ItoY, BringasPJr., ChaiY. 2005. Functional significance of Smad2 in regulating basal keratinocyte migration during wound healing. J Invest Dermatol, 125:1302–1309.
70.
MatsubayashiY, EbisuyaM, HonjohS, NishidaE. 2004. ERK activation propagates in epithelial cell sheets and regulates their migration during wound healing. Curr Biol, 14:731–735.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
